cis-Retinoic acid stimulates the clonal growth of some myeloid leukemia cells in vitro

H. J. Lawrence, K. Conner, M. A. Kelly, M. R. Haussler, P. Wallace, G. C. Bagby

Research output: Contribution to journalArticle

30 Citations (Scopus)

Abstract

We studied the effects of cis-retinoic acid (cisRA) on the clonogenic growth of samples of leukemic cells from 35 patients with acute nonlymphocytic leukemia (ANLL). We observed significant inhibition of leukemic colony growth in 17 samples by 10-7 to 10-6 M cisRA. However, we found that retinoic exposure resulted in striking stimulation of clonal growth in ten samples at the same drug concentrations. With the exception of cases with promyelocytic features, there was no morphologic or functiona evidence that cisRA induced the leukemic blasts to differentiate. Both inhibition and stimulation were dose-dependent and observable at pharmacologically achievable levels of cisRA. Leukemic cells with monocytic features more frequently demonstrated a stimulatory response than did those without monocytic features. Depletion of T lymphocytes and monocytes did not alter the type of growth response. Assays for cellular retinoic acid-binding protein (CRABP) were performed on five samples (two with inhibitory growth responses, two with stimulatory responses, and one with no growth) and failed to reveal detectable levels of CRABP in any case. The addition of cisRA to liquid suspensions of leukemic cells produced no significant change in the number of viable cells. We conclude that the effects of cisRA on leukemic colony growth are not cytotoxic and not mediated by T lymphocytes, monocytes, or CRABP. More importantly, cisRA appears to enhance the growth of certain human leukemia cells in vitro. Taking into account the increasing use of retinoids in clinical trials for patients with leukemia, the latter findings may represent a significant cautionary note.

Original languageEnglish (US)
Pages (from-to)302-307
Number of pages6
JournalBlood
Volume69
Issue number1
StatePublished - 1987
Externally publishedYes

Fingerprint

NSC 153174
Myeloid Leukemia
Myeloid Cells
Tretinoin
Growth
Retinoic Acid Receptors
T-cells
Monocytes
Leukemia
T-Lymphocytes
In Vitro Techniques
Retinoids

ASJC Scopus subject areas

  • Hematology

Cite this

Lawrence, H. J., Conner, K., Kelly, M. A., Haussler, M. R., Wallace, P., & Bagby, G. C. (1987). cis-Retinoic acid stimulates the clonal growth of some myeloid leukemia cells in vitro. Blood, 69(1), 302-307.

cis-Retinoic acid stimulates the clonal growth of some myeloid leukemia cells in vitro. / Lawrence, H. J.; Conner, K.; Kelly, M. A.; Haussler, M. R.; Wallace, P.; Bagby, G. C.

In: Blood, Vol. 69, No. 1, 1987, p. 302-307.

Research output: Contribution to journalArticle

Lawrence, HJ, Conner, K, Kelly, MA, Haussler, MR, Wallace, P & Bagby, GC 1987, 'cis-Retinoic acid stimulates the clonal growth of some myeloid leukemia cells in vitro', Blood, vol. 69, no. 1, pp. 302-307.
Lawrence HJ, Conner K, Kelly MA, Haussler MR, Wallace P, Bagby GC. cis-Retinoic acid stimulates the clonal growth of some myeloid leukemia cells in vitro. Blood. 1987;69(1):302-307.
Lawrence, H. J. ; Conner, K. ; Kelly, M. A. ; Haussler, M. R. ; Wallace, P. ; Bagby, G. C. / cis-Retinoic acid stimulates the clonal growth of some myeloid leukemia cells in vitro. In: Blood. 1987 ; Vol. 69, No. 1. pp. 302-307.
@article{2ef3b274b5444fe1bea937ece71903b7,
title = "cis-Retinoic acid stimulates the clonal growth of some myeloid leukemia cells in vitro",
abstract = "We studied the effects of cis-retinoic acid (cisRA) on the clonogenic growth of samples of leukemic cells from 35 patients with acute nonlymphocytic leukemia (ANLL). We observed significant inhibition of leukemic colony growth in 17 samples by 10-7 to 10-6 M cisRA. However, we found that retinoic exposure resulted in striking stimulation of clonal growth in ten samples at the same drug concentrations. With the exception of cases with promyelocytic features, there was no morphologic or functiona evidence that cisRA induced the leukemic blasts to differentiate. Both inhibition and stimulation were dose-dependent and observable at pharmacologically achievable levels of cisRA. Leukemic cells with monocytic features more frequently demonstrated a stimulatory response than did those without monocytic features. Depletion of T lymphocytes and monocytes did not alter the type of growth response. Assays for cellular retinoic acid-binding protein (CRABP) were performed on five samples (two with inhibitory growth responses, two with stimulatory responses, and one with no growth) and failed to reveal detectable levels of CRABP in any case. The addition of cisRA to liquid suspensions of leukemic cells produced no significant change in the number of viable cells. We conclude that the effects of cisRA on leukemic colony growth are not cytotoxic and not mediated by T lymphocytes, monocytes, or CRABP. More importantly, cisRA appears to enhance the growth of certain human leukemia cells in vitro. Taking into account the increasing use of retinoids in clinical trials for patients with leukemia, the latter findings may represent a significant cautionary note.",
author = "Lawrence, {H. J.} and K. Conner and Kelly, {M. A.} and Haussler, {M. R.} and P. Wallace and Bagby, {G. C.}",
year = "1987",
language = "English (US)",
volume = "69",
pages = "302--307",
journal = "Blood",
issn = "0006-4971",
publisher = "American Society of Hematology",
number = "1",

}

TY - JOUR

T1 - cis-Retinoic acid stimulates the clonal growth of some myeloid leukemia cells in vitro

AU - Lawrence, H. J.

AU - Conner, K.

AU - Kelly, M. A.

AU - Haussler, M. R.

AU - Wallace, P.

AU - Bagby, G. C.

PY - 1987

Y1 - 1987

N2 - We studied the effects of cis-retinoic acid (cisRA) on the clonogenic growth of samples of leukemic cells from 35 patients with acute nonlymphocytic leukemia (ANLL). We observed significant inhibition of leukemic colony growth in 17 samples by 10-7 to 10-6 M cisRA. However, we found that retinoic exposure resulted in striking stimulation of clonal growth in ten samples at the same drug concentrations. With the exception of cases with promyelocytic features, there was no morphologic or functiona evidence that cisRA induced the leukemic blasts to differentiate. Both inhibition and stimulation were dose-dependent and observable at pharmacologically achievable levels of cisRA. Leukemic cells with monocytic features more frequently demonstrated a stimulatory response than did those without monocytic features. Depletion of T lymphocytes and monocytes did not alter the type of growth response. Assays for cellular retinoic acid-binding protein (CRABP) were performed on five samples (two with inhibitory growth responses, two with stimulatory responses, and one with no growth) and failed to reveal detectable levels of CRABP in any case. The addition of cisRA to liquid suspensions of leukemic cells produced no significant change in the number of viable cells. We conclude that the effects of cisRA on leukemic colony growth are not cytotoxic and not mediated by T lymphocytes, monocytes, or CRABP. More importantly, cisRA appears to enhance the growth of certain human leukemia cells in vitro. Taking into account the increasing use of retinoids in clinical trials for patients with leukemia, the latter findings may represent a significant cautionary note.

AB - We studied the effects of cis-retinoic acid (cisRA) on the clonogenic growth of samples of leukemic cells from 35 patients with acute nonlymphocytic leukemia (ANLL). We observed significant inhibition of leukemic colony growth in 17 samples by 10-7 to 10-6 M cisRA. However, we found that retinoic exposure resulted in striking stimulation of clonal growth in ten samples at the same drug concentrations. With the exception of cases with promyelocytic features, there was no morphologic or functiona evidence that cisRA induced the leukemic blasts to differentiate. Both inhibition and stimulation were dose-dependent and observable at pharmacologically achievable levels of cisRA. Leukemic cells with monocytic features more frequently demonstrated a stimulatory response than did those without monocytic features. Depletion of T lymphocytes and monocytes did not alter the type of growth response. Assays for cellular retinoic acid-binding protein (CRABP) were performed on five samples (two with inhibitory growth responses, two with stimulatory responses, and one with no growth) and failed to reveal detectable levels of CRABP in any case. The addition of cisRA to liquid suspensions of leukemic cells produced no significant change in the number of viable cells. We conclude that the effects of cisRA on leukemic colony growth are not cytotoxic and not mediated by T lymphocytes, monocytes, or CRABP. More importantly, cisRA appears to enhance the growth of certain human leukemia cells in vitro. Taking into account the increasing use of retinoids in clinical trials for patients with leukemia, the latter findings may represent a significant cautionary note.

UR - http://www.scopus.com/inward/record.url?scp=0023137595&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0023137595&partnerID=8YFLogxK

M3 - Article

C2 - 3024759

AN - SCOPUS:0023137595

VL - 69

SP - 302

EP - 307

JO - Blood

JF - Blood

SN - 0006-4971

IS - 1

ER -